Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.089B Est
Moderna (NASDAQ: MRNA ) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.089 billion estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.